Atossa Therapeutics
ATOS
#9237
Rank
A$0.15 B
Marketcap
A$1.20
Share price
5.24%
Change (1 day)
-35.32%
Change (1 year)

Market capitalization of Atossa Therapeutics (ATOS)

Market cap: A$0.15 Billion

As of December 2025 Atossa Therapeutics has a market cap of A$0.15 Billion. This makes Atossa Therapeutics the world's 9237th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Atossa Therapeutics from 2012 to 2025

End of year Market Cap

Year Marketcap Change
2025A$0.15 B-21.67%
2024A$0.19 B22.6%
2023A$0.16 B64.58%
2022A$98.34 M-64.81%
2021A$0.27 B375.7%
2020A$58.74 M186.91%
2019A$20.47 M141.88%
2018A$8.46 M-21.04%
2017A$10.72 M44.68%
2016A$7.4 M-48.35%
2015A$14.34 M-66.58%
2014A$42.92 M-11.16%
2013A$48.31 M-0.36%
2012A$48.48 M

End of Day market cap according to different sources

On Dec 5th, 2025 the market cap of Atossa Therapeutics was reported to be:

A$0.15 Billion
by Nasdaq info icon info icon
A$0.15 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Johnson & Johnson
JNJ
A$732.43 B 471,110.08%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
A$32.32 B 20,696.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
A$30.72 B 19,667.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
A$55.08 M-64.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Translate Bio
TBIO.defunct
A$4.25 B 2,635.12%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
A$2.31 B 1,391.30%๐Ÿ‡บ๐Ÿ‡ธ USA